Literature DB >> 15147633

Expression pattern of apolipoprotein M during mouse and human embryogenesis.

Xiao-Ying Zhang1, Guo-Qing Jiao, Maria Hurtig, Xuan Dong, Lu Zheng, Guang-Hua Luo, Peter Nilsson-Ehle, Qing Ye, Ning Xu.   

Abstract

Apolipoprotein M (apoM) is a recently discovered human apolipoprotein predominantly present in high-density lipoprotein (HDL), and in minor proportions in triglyceride-rich lipoprotein (TGRLP) and low-density lipoprotein (LDL). The gene encoding apoM is present in all mammalian genomes. The identity of the apoM gene of human, rat and mouse is over 80%. However, the (patho)physiological functions of apoM are unknown yet. In the present study, we investigated apoM expression patterns during mouse and human embryogenesis. ApoM transcripts were detectable in mouse embryos from day 7.5 to day 18.5. ApoM was expressed at low levels at day 7.5, its expression increased significantly at day 9.7, decreased at day 10.5, and then increased continually up to day 18.5. ApoM-positive cells appeared mainly in liver of day-12 embryos as detected by in situ hybridization. In day-15 embryos, apoM was expressed in both liver and kidney. During human embryogenesis, apoM was mainly expressed in liver and kidney and little was found in small intestine as determined by mRNA array of human fetal normal tissues. ApoM was also detected in stomach and skeletal muscle in early stages of embryogenesis (3-5 months).

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15147633     DOI: 10.1016/j.acthis.2003.11.004

Source DB:  PubMed          Journal:  Acta Histochem        ISSN: 0065-1281            Impact factor:   2.479


  10 in total

Review 1.  Vascular and Immunobiology of the Circulatory Sphingosine 1-Phosphate Gradient.

Authors:  Keisuke Yanagida; Timothy Hla
Journal:  Annu Rev Physiol       Date:  2016-10-21       Impact factor: 19.318

2.  Impaired endothelial barrier function in apolipoprotein M-deficient mice is dependent on sphingosine-1-phosphate receptor 1.

Authors:  Pernille M Christensen; Catherine H Liu; Steven L Swendeman; Hideru Obinata; Klaus Qvortrup; Lars B Nielsen; Timothy Hla; Annarita Di Lorenzo; Christina Christoffersen
Journal:  FASEB J       Date:  2016-03-08       Impact factor: 5.191

3.  Expression and localization of apolipoprotein M in human colorectal tissues.

Authors:  Guanghua Luo; Xiaoying Zhang; Qinfeng Mu; Lujun Chen; Lu Zheng; Jiang Wei; Maria Berggren-Söderlund; Peter Nilsson-Ehle; Ning Xu
Journal:  Lipids Health Dis       Date:  2010-09-16       Impact factor: 3.876

4.  Enchanced levels of apolipoprotein M during HBV infection feedback suppresses HBV replication.

Authors:  Jin-Gang Gu; Cheng-liang Zhu; Duo-zhi Cheng; Yan Xie; Fang Liu; Xin Zhou
Journal:  Lipids Health Dis       Date:  2011-08-29       Impact factor: 3.876

5.  Apolipoprotein M.

Authors:  Guanghua Luo; Xiaoying Zhang; Peter Nilsson-Ehle; Ning Xu
Journal:  Lipids Health Dis       Date:  2004-10-04       Impact factor: 3.876

6.  17β-estradiol regulates the expression of apolipoprotein M through estrogen receptor α-specific binding motif in its promoter.

Authors:  Jiang Wei; Yang Yu; Guang-Hua Luo; Yue-Hua Feng; Yuan-Ping Shi; Jun Zhang; Qin-Feng Mu; Miao-Mei Yu; Li-Li Pan; Maria Berggren-Söderlund; Peter Nilsson-Ehle; Xiao-Ying Zhang; Ning Xu
Journal:  Lipids Health Dis       Date:  2017-03-31       Impact factor: 3.876

7.  Apolipoprotein M promotes the anti-inflammatory effect of high-density lipoprotein by binding to scavenger receptor BI.

Authors:  Shuang Yao; Guanghua Luo; Hong Liu; Jun Zhang; Yuxia Zhan; Ning Xu; Xiaoying Zhang; Lu Zheng
Journal:  Ann Transl Med       Date:  2020-12

8.  Dihydrotestosterone regulating apolipoprotein M expression mediates via protein kinase C in HepG2 cells.

Authors:  Ye Yi-zhou; Cao Bing; Li Ming-qiu; Wang Wei; Wang Ru-xing; Rui Jun; Wei Liu-yan; Jing Zhao-hui; Ji Yong; Jiao Guo qing; Zou Jian
Journal:  Lipids Health Dis       Date:  2012-12-05       Impact factor: 3.876

9.  Dihydrocapsaicin down-regulates apoM expression through inhibiting Foxa2 expression and enhancing LXRα expression in HepG2 cells.

Authors:  Jia-Yi Zhao; Yan-Wei Hu; Shu-Fen Li; Ya-Rong Hu; Xin Ma; Shao-Guo Wu; Yan-Chao Wang; Ji-Juan Gao; Yan-Hua Sha; Lei Zheng; Qian Wang
Journal:  Lipids Health Dis       Date:  2014-03-19       Impact factor: 3.876

10.  Increased apolipoprotein M induced by lack of scavenger receptor BI is not activated via HDL-mediated cholesterol uptake in hepatocytes.

Authors:  Yue-Hua Feng; Lu Zheng; Jiang Wei; Miao-Mei Yu; Jun Zhang; Guang-Hua Luo; Ning Xu
Journal:  Lipids Health Dis       Date:  2018-08-25       Impact factor: 3.876

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.